72 days ago
Yesterday Hemogenyx (HEMO) announced that it had signed a letter of intent with Cellin Technologies OU in Estonia claiming that this “represents the first near term revenue opportunity.” Let me and also a qualified doctor with expertise in clinical trials, explain why that is just Vlad Sandler over-egging the pudding big time.. And why that ultimately consigns all involved in this spoof to a special place in hell.